Table 4. Differential expression of the biomarkers in relation to pT stage.
Location | Biomarker | pT2 | pT3 | SD between patients | SD within patients | P-value |
---|---|---|---|---|---|---|
Epithelium | Shh* | 8.3 | 7.7 | 2.2 | 1.9 | 0.159 |
SMO* | 9.4 | 9 | 1.3 | 1.4 | 0.233 | |
Ptch* | 1.4 | 3.1 | 2.2 | 1.8 | <0.001 | |
Gli1* | 6.5 | 7.4 | 2.8 | 1.6 | 0.066 | |
ki67** | 1.1 | 5 | 6.5 | 3 | 0.152 | |
VEGF* | 7.7 | 7.3 | 2.4 | 2 | 0.33 | |
| ||||||
Stroma | Shh* | 1.1 | 0.9 | 0.5 | 0.6 | 0.059 |
SMO* | 4.3 | 4 | 2 | 1.7 | 0.453 | |
Ptch* | 8.2 | 7.3 | 1.2 | 1.5 | <0.001 | |
Gli1* | 4.2 | 3.9 | 2 | 1.9 | 0.53 | |
VEGF* | 2.6 | 2 | 1.2 | 1.2 | 0.003 | |
CD31*** | 19 | 22 | 7 | 7 | 0.012 |
11-point scale system.
Percentage of positive cells.
CD31-positive vessels per core.
SD: standard deviation; VEGF: vascular endothelial growth factor.